For a patient with normal spirometry and bronchodilator testing, should I still presume asthma and what is the next step in management?

Normal Spirometry with Bronchodilator Testing: Next Steps in Suspected Asthma

When spirometry with bronchodilator testing is normal in a patient with suspected asthma, you should proceed with bronchoprovocation challenge testing (methacholine challenge) to confirm or exclude the diagnosis, as this has excellent negative predictive value approaching 100% for ruling out asthma 1, 2.

Why Normal Spirometry Doesn't Exclude Asthma

Normal spirometry is common in patients with mild or well-controlled asthma who are not symptomatic at the time of testing 3. The sensitivity of a single spirometry test is low, and many patients with genuine asthma will have normal baseline lung function 4. A negative bronchodilator response has only a 57% negative predictive value for excluding asthma 4, meaning nearly half of patients with true asthma may have normal testing.

The Diagnostic Algorithm

Step 1: Perform Bronchoprovocation Challenge Testing

Bronchoprovocation with methacholine is the next appropriate test when asthma is suspected and spirometry is normal or near normal 1. This test:

• Has a negative predictive value close to 100% - a negative test effectively rules out asthma 5, 6
• Has a positive predictive value of 60-88% - a positive test is consistent with asthma but not definitive 5
• Should be performed only by trained personnel for safety reasons 1

A PC20 (provocative concentration causing 20% drop in FEV1) of less than 8 mg/mL is considered positive and warrants a trial of asthma treatment 5, 7.

Step 2: Consider Clinical Predictors

Before proceeding to bronchoprovocation, assess these high-yield clinical features that increase likelihood of asthma 7:

• Symptoms provoked by exercise or cold air (97% sensitivity for asthma diagnosis)
• Female sex
• Lower pre-bronchodilator FEV1 percentage predicted (even if still "normal")
• Any positive bronchodilator response (even if below diagnostic threshold)
• Presence of prebronchodilator airflow limitation increases odds of positive methacholine test by 1.9-fold 4

Step 3: Alternative/Adjunctive Testing

If bronchoprovocation is unavailable or cannot be performed, consider:

Peak Flow Monitoring 1, 8:

• Monitor twice daily for 2 weeks
• Calculate amplitude % best: (highest - lowest)/highest × 100
• ≥20% variability with minimum 60 L/min change is highly suggestive of asthma
• This is specific but insensitive - smaller changes don't exclude asthma 8

FeNO Testing 9:

• Use as adjunct when diagnosis remains uncertain after spirometry
• Elevated FeNO supports asthma diagnosis, especially in allergic/atopic patients
• Cannot be used alone to diagnose asthma - only as supportive evidence
• Less useful in non-allergic presentations

Exercise Challenge 1, 8:

• Measure baseline spirometry, exercise for 6 minutes, then measure every 10 minutes for 30 minutes
• Look for ≥20% decrease in PEF (minimum 60 L/min) or ≥15% decrease in FEV1 (minimum 200 mL)
• Requires immediate treatment availability

Step 4: Empiric Treatment Trial (If Testing Unavailable)

When bronchoprovocation cannot be performed and clinical suspicion remains high 5, 10:

1. Start inhaled corticosteroids (ICS) plus bronchodilators as first-line therapy 2, 10
2. Expect response within 1 week for most patients, but complete cough resolution may take up to 8 weeks 5
3. If inadequate response to inhaled therapy, consider:
   • Adding leukotriene receptor antagonist 5, 2
   • Short course of oral corticosteroids (prednisone 40 mg/day for 5-10 days or 30 mg/day for 14 days) 5, 8
4. Diagnosis is confirmed only if symptoms resolve with specific asthma therapy 10

Critical Pitfalls to Avoid

Don't assume asthma is excluded based on normal spirometry alone - this is insufficient 1, 8. Spirometry may be repeatedly normal in mild asthma between symptomatic episodes 3.

Don't forget alternative diagnoses 1:

• Vocal cord dysfunction (check for inspiratory flow-volume loop flattening)
• Upper airway cough syndrome (formerly post-nasal drip)
• GERD (especially if no GERD symptoms but failed other treatments)
• Non-asthmatic eosinophilic bronchitis (requires sputum eosinophil testing)

Timing matters - consider repeating tests during symptomatic periods or after exposure to known triggers 11. Asthma demonstrates temporal variability, and testing during asymptomatic periods may miss the diagnosis.

If methacholine challenge is negative but clinical suspicion remains high, consider repeating the test 4:

• MCT can convert from negative to positive spontaneously over time in 15% of cases
• If patient is on controller medications, taper and retest (converts to positive in 19% of cases)
• Some patients with genuine asthma may have persistently negative MCT but still warrant clinical diagnosis based on symptoms and treatment response

When to Reconsider the Diagnosis

If bronchoprovocation is negative in an untreated patient with suspected asthma, this should prompt serious reconsideration of the diagnosis 8. However, approximately 12% of patients with negative MCT may still receive an asthma diagnosis from a pulmonologist based on clinical grounds 4, so clinical judgment remains paramount when suspicion is high.